CNS Pharmaceuticals (CNSP) Provides Clinical Trial Update for Ongoing Study with Berubicin streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) Short Interest Up 7.2% in June theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Free Report) saw a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 222,600 shares, an increase of 7.2% from the June 15th total of 207,600 shares. Based on an average trading volume of 3,600,000 shares, the short-interest ratio […]
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Rating) saw a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 229,100 shares, a growth of 91.6% from the May 15th total of 119,600 shares. Based on an average daily trading volume, of 3,560,000 shares, the days-to-cover ratio […]
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Rating) was the recipient of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 229,100 shares, a growth of 91.6% from the May 15th total of 119,600 shares. Approximately 5.7% of the company’s stock are short sold. Based […]